SEHK:1952Biotechs
Everest Medicines (SEHK:1952) Valuation Check After Recent Share Price Volatility
What is moving Everest Medicines after recent performance
Everest Medicines (SEHK:1952) has caught investor attention after a recent 2.5% one-day return, which contrasts with a decline of about 17.8% over the past three months and a modest gain over the past year.
See our latest analysis for Everest Medicines.
That 2.5% one day share price gain comes after a 90 day share price return of about an 18% decline, while the 1 year total shareholder return of around 5% hints that shorter term...